Literature DB >> 6815854

Postoperative prophylactic intravesical instillation of cytosine arabinoside and mitomycin C in superficial bladder tumor. A follow-up study.

T Omoto, M Kano, A Ariyoshi, S Momose, Z Masaki, I Morita, N Ishisawa.   

Abstract

A follow-up study was made on 225 Japanese patients with superficial bladder tumors who were treated postoperatively with intravesical instillation of cytosine arabinoside and mitomycin C nineteen times during one year. Cumulative recurrence rates of the tumor were 16.7 and 41.9 per cent during the first 1 and 3.5 years after surgery, respectively. These results are superior to the previous findings in cases in which instillation therapy was not given. Histologically, there was no definite difference in recurrence among the groups with low-grade and high-grade tumors. The recurrence rate of multiple tumors was higher than that of a solitary tumor. Earlier postoperative instillation appeared to be more effective during the initial one year after surgery.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815854     DOI: 10.1016/0090-4295(82)90125-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract.

Authors:  Xiaheng Deng; Xiao Yang; Yidong Cheng; Xuzhong Liu; Bian Wu; Zijie Wang; Zhengkai Huang; Kang Liu; Ruizhe Zhao; Jun Wang; Qiang Lu; Chao Qin; Changjun Yin
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer.

Authors:  T Tsushima; Y Matsumura; Y Ozaki; J Yoshimoto; H Ohmori
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  A phase II study of prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer: comparison of 4'-epirubicin and adriamycin.

Authors:  T Shuin; Y Kubota; S Noguchi; M Hosaka; T Miura; I Kondo; S Fukushima; E Ishizuka; A Furuhata; M Moriyama
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

4.  Recurrence of superficial bladder tumours after transurethral resection.

Authors:  H Fuse; T Sakai; H Kimura; T Katayama
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

5.  Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results. The Hokkaido University Bladder Cancer Collaborating Group.

Authors:  M Togashi; N Shinohara; K Toyota; T Koyanagi; A Maru; J Fujieda; K Kawakura; T Nishida; N Ohashi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.

Authors:  T Ueda; S Naito; A Iguchi; K Sagiyama; Y Osada; A Ariyoshi; T Omoto; J Kumazawa
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Early intravesical instillation of adriamycin with oral administration of 5-fluorouracil after transurethral resection for superficial bladder cancer: preliminary results.

Authors:  T Ueda; A Iguchi; K Sagiyama; Y Osada; A Ariyoshi; T Omoto; J Kumazawa
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non-muscle-invasive bladder cancer: a randomised clinical trial.

Authors:  Yasuyoshi Miyata; Toshifumi Tsurusaki; Yasushi Hayashida; Yushi Imasato; Kosuke Takehara; Daiyu Aoki; Masaharu Nishikido; Junichi Watanabe; Kensuke Mitsunari; Tomohiro Matsuo; Kojiro Ohba; Keisuke Taniguchi; Hideki Sakai
Journal:  BJU Int       Date:  2021-08-24       Impact factor: 5.969

9.  Wound healing in patients with cancer.

Authors:  Wyatt G Payne; Deepak K Naidu; Chad K Wheeler; David Barkoe; Marni Mentis; R Emerick Salas; David J Smith; Martin C Robson
Journal:  Eplasty       Date:  2008-01-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.